Protein inhibitor of activated STAT1 Ser503 phosphorylation‐mediated Elk‐1 SUMOylation promotes neuronal survival in APP/PS1 mice
Open Access
- 8 March 2019
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 176 (11) , 1793-1810
Abstract
Background and Purpose: Protein inhibitor of activated STAT1 (PIAS1) is phosphorylated by IKKα at Ser90 in a PIAS1 E3 ligase activity‐dependent manner. Whether PIAS1 is also phosphorylated at other residues and the functional significance of these additional phosphorylation events are not known. The transcription factor Elk‐1 remains SUMOylated under basal conditions, but the role of Elk‐1 SUMOylation in brain is unknown. Here, we examined the functional significance of PIAS1‐mediated Elk‐1 SUMOylation in Alzheimer's disease (AD) using the APP/PS1 mouse model of AD and amyloid β (Aβ) microinjections in vivo.Experimental Approach: Novel phosphorylation site(s) on PIAS1 were identified by LC–MS/MS, and MAPK/ERK‐mediated phosphorylation of Elk‐1 demonstrated using in vitro kinase assays. Elk‐1 SUMOylation by PIAS1 in brain was determined using in vitro SUMOylation assays. Apoptosis in hippocampus was assessed by measuring GADD45α expression by western blotting, and apoptosis of hippocampal neurons in APP/PS1 mice was assessed by TUNEL assay.Key Results: Using LC–MS/MS, we identified a novel MAPK/ERK‐mediated phosphorylation site on PIAS1 at Ser503 and showed this phosphorylation determines PIAS1 E3 ligase activity. In rat brain, Elk‐1 was SUMOylated by PIAS1, which decreased Elk‐1 phosphorylation and down‐regulated GADD45α expression. Moreover, lentiviral‐mediated transduction of Elk‐1‐SUMO1 reduced the number of hippocampal apoptotic neurons in APP/PS1 mice.Conclusions and Implications: MAPK/ERK‐mediated phosphorylation of PIAS1 at Ser503 determines PIAS1 E3 ligase activity. Moreover, PIAS1 mediates SUMOylation of Elk‐1, which functions as an endogenous defence mechanism against Aβ toxicity in vivo. Targeting Elk‐1 SUMOylation could be considered a novel therapeutic strategy against AD.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 107‐2320‐B‐001‐020)
This publication has 54 references indexed in Scilit:
- Laminin-β1 Impairs Spatial Learning through Inhibition of ERK/MAPK and SGK1 SignalingNeuropsychopharmacology, 2011
- The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT CellsJournal of Biological Chemistry, 2011
- The SUMO E3‐ligase PIAS1 couples reactive oxygen species‐dependent JNK activation to oxidative cell deathThe FASEB Journal, 2011
- Elk-1 a Transcription Factor with Multiple Facets in the BrainFrontiers in Neuroscience, 2011
- The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognitionNature Reviews Molecular Cell Biology, 2010
- Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learningThe EMBO Journal, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by SumoylationMolecular and Cellular Biology, 2005
- Negative Regulation of NF-κB Signaling by PIAS1Molecular and Cellular Biology, 2005
- Identification of β-Amyloid-Responsive Genes by RNA Differential Display: Early Induction of a DNA Damage-Inducible Gene, gadd45Experimental Neurology, 1999